Drug factory · FDA FEI 3002807299

Interpharma Praha, a.s.

Prague 12, Czech Republic

Matched to FDA's records by company name, because this plant's registration on the label has expired.

Serious problems, FDA action at FDA's last inspection, Oct 16, 2015.

Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.

2 drug inspections on record since 2012: 1 with no problems, 0 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

Drug	Role	For	NDC
Iohexol	Makes it, makes the active ingredient and tests it	Interpharma Praha, a.s.	54702-501

Ended	Result	Program	Problems noted
Oct 16, 2015	Serious problems, FDA action	Drug Quality Assurance	—
Aug 23, 2012	No problems found	Drug Quality Assurance	—